关注
Carmelo SCARPIGNATO, MD, DSc, PharmD, FRCP, FCP, FACG
Carmelo SCARPIGNATO, MD, DSc, PharmD, FRCP, FCP, FACG
Professor of Pharmacology & Therapeutics, University of Parma
在 unipr.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Myths and misconceptions about chronic constipation
SA Müller-Lissner, MA Kamm, C Scarpignato, A Wald
Official journal of the American College of Gastroenterology| ACG 100 (1 …, 2005
7662005
The burden of constipation on quality of life: results of a multinational survey
A Wald, C Scarpignato, MA Kamm, S Mueller‐Lissner, I Helfrich, C Schuijt, ...
Alimentary pharmacology & therapeutics 26 (2), 227-236, 2007
4962007
Caustic injury of the upper gastrointestinal tract: a comprehensive review
S Contini, C Scarpignato
World journal of gastroenterology: WJG 19 (25), 3918, 2013
4662013
Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs
I Bjarnason, C Scarpignato, E Holmgren, M Olszewski, KD Rainsford, ...
Gastroenterology 154 (3), 500-514, 2018
4602018
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
L Gatta, N Vakil, D Vaira, C Scarpignato
Bmj 347, 2013
3852013
Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression
C Scarpignato, L Gatta, A Zullo, C Blandizzi, ...
BMC medicine 14, 1-35, 2016
3792016
A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation
A Wald, C Scarpignato, S Mueller‐Lissner, MA Kamm, U Hinkel, I Helfrich, ...
Alimentary pharmacology & therapeutics 28 (7), 917-930, 2008
3552008
Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention
C Scarpignato, RH Hunt
Gastroenterology Clinics 39 (3), 433-464, 2010
3382010
Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential
C Scarpignato, I Pelosini
Chemotherapy 51 (Suppl. 1), 36-66, 2005
3352005
Reflux related symptoms in patients with normal oesophageal exposure to acid.
G Shi, SB Des Varannes, C Scarpignato, M Le Rhun, JP Galmiche
Gut 37 (4), 457-464, 1995
3131995
Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus addressing benefits as well as gastrointestinal and cardiovascular …
C Scarpignato, A Lanas, C Blandizzi, WF Lems, M Hermann, RH Hunt, ...
BMC medicine 13, 1-22, 2015
3012015
Proton pump inhibitors in GORD: an overview of their pharmacology, efficacy and safety
V Savarino, F Di Mario, C Scarpignato
Pharmacological Research 59 (3), 135-153, 2009
2762009
Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
L Gatta, C Scarpignato, RW McCallum, L Lombardo, M Pimentel, R D'Incà, ...
Alimentary pharmacology & therapeutics 45 (5), 604-616, 2017
2572017
Italian consensus conference for colonic diverticulosis and diverticular disease
R Cuomo, G Barbara, F Pace, V Annese, G Bassotti, GA Binda, T Casetti, ...
United European gastroenterology journal 2 (5), 413-442, 2014
2292014
Action of caerulein on gastric emptying of the conscious rat.
C Scarpignato, T Capovilla, G Bertaccini
Archives Internationales de Pharmacodynamie et de Therapie 246 (2), 286-294, 1980
2111980
Colonic diverticular disease
A Tursi, C Scarpignato, LL Strate, A Lanas, W Kruis, A Lahat, S Danese
Nature Reviews Disease Primers 6 (1), 20, 2020
2052020
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
G Burmester, A Lanas, L Biasucci, M Hermann, S Lohmander, I Olivieri, ...
Annals of the rheumatic diseases 70 (5), 818-822, 2011
1912011
Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic
C Scarpignato, I Pelosini
Digestion 73 (Suppl. 1), 13-27, 2006
1682006
COVID-19 and gastrointestinal disease: implications for the gastroenterologist
RH Hunt, JE East, A Lanas, P Malfertheiner, J Satsangi, C Scarpignato, ...
Digestive Diseases 39 (2), 119-139, 2021
1662021
Acid suppression therapy: where do we go from here?
C Scarpignato, I Pelosini, F Di Mario
Digestive Diseases 24 (1-2), 11-46, 2006
1642006
系统目前无法执行此操作,请稍后再试。
文章 1–20